As we have seen with GLP-1 drugs, once a therapy demonstrates both biological efficacy and real-world impact, adoption can accelerate very quickly. Whether through stem cell activation, immune modulation, reformulated legacy drugs, or regenerative medicine, the next generation of hair loss therapies is no longer chasing incremental improvement
Retatrutide is not TGA-approved for therapeutic use in Australia
The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists
In a study by Joon and Parle, Shatavari reversed autistic symptoms in rat pups by correcting oxidative stress indicators and regulating neurotransmitter levels
Metformin, an activator of AMPK and LKB1, could decrease hepatic tissue insulin resistance, and prolonged survival was observed in cancerous metformin users (Sadeghi et al., 2012